Publication date: Oct 07, 2024
Enhancing the clinical trial capabilities within Africa is essential to augment the continent’s pandemic prevention, preparedness and response efforts. Here, we describe the critical challenges of clinical trials in Africa and draw upon the lessons learnt from the Consortium for COVID-19 Vaccine Clinical Trials (CONCVACT) experience, such as the importance of regional collaboration, capacity building and establishing standardized protocols.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Africa | Africa |
| Expanding | Capacity Building |
| Lessons | COVID-19 |
| Pandemic | Humans |
| Vaccine | Pandemics |
| SARS-CoV-2 |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | IDO | pathogen |
| disease | IDO | quality |
| disease | MESH | COVID 19 |
| disease | MESH | emergencies |
| drug | DRUGBANK | Pirenzepine |
| disease | MESH | AIDS |
| disease | MESH | Hepatitis |
| disease | MESH | infectious diseases |
| disease | MESH | non communicable diseases |
| disease | IDO | production |
| drug | DRUGBANK | Etoperidone |
| drug | DRUGBANK | Icodextrin |
| disease | IDO | site |
| drug | DRUGBANK | Coenzyme M |
| drug | DRUGBANK | L-Isoleucine |
| disease | MESH | infection |
| pathway | REACTOME | Reproduction |
Original Article
(Visited 2 times, 1 visits today)